Publicacions en què col·labora amb Ana Eugenia Rodríguez Vicente (7)

2020

  1. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612

2015

  1. MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL

    BMC Cancer, Vol. 15, Núm. 1

2014

  1. TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations

    BioMed Research International, Vol. 2014

2012

  1. Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling

    Annals of Oncology, Vol. 23, Núm. 8, pp. 2138-2146

  2. Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression

    Pharmacogenetics and Genomics, Vol. 22, Núm. 5, pp. 381-388

  3. Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14

    PLoS ONE, Vol. 7, Núm. 11

2010

  1. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma

    Genes Chromosomes and Cancer, Vol. 49, Núm. 5, pp. 439-451